To date, Health Canada has approved 37 clinical trials for potential COVID-19 therapies and vaccines. To accelerate these efforts, the Honourable Patty Hajdu, Minister of Health, has authorized the following change for a more flexible process for clinical trials related to COVID-19, without compromising the safety of participants or the reliability of trials' findings:
"We have made progress against COVID-19 by following public health advice, and we need to keep going. We also know that it will take time before a vaccine or treatments are available, and this is why we are making these changes to help the medical community work as quickly and safely as possible."
The Honourable Patty Hajdu
Minister of Health
Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19
Clinical Trials and Drug Safety
Drugs and vaccines for COVID-19: Conducting a clinical trial
Medical devices for COVID-19: Conducting a clinical trial
Joint Statement on Clinical Trial Oversight in Canada
SOURCE Health Canada
For further information: Contacts: Cole Davidson, Office of the Honourable Patty Hajdu, Minister of Health, 613-957-0200; Media Relations, Health Canada, 613-957-2983, firstname.lastname@example.org; Public Inquiries: 613-957-2991, 1-866-225-0709
To read more Press Release articles, click here.